18 results
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
clinical trials and upon any commercialization of any product candidates. Inadequate training in recognizing or managing the potential side effects … and to prevent security breaches, including costs related to deploying additional personnel and protection technologies, training employees, and engaging
DEF 14A
PNT
POINT Biopharma Global Inc.
28 Apr 22
Definitive proxy
8:36am
degree from the University of Toronto in 1988. He completed specialty training in urologic surgery and oncology from 1993 to 1996, received a Master’s … in Public Health in epidemiology from Columbia University in 1997, and completed his oncology training at Memorial Sloan-Kettering Cancer Center. Dr
424B3
pa13uz7
31 Mar 22
Prospectus supplement
11:42am
POS AM
bgkay3 mg
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
424B3
xtigwkqkdvf0
5 Aug 21
Prospectus supplement
4:26pm
424B3
y32b5bq hw3
9 Jun 21
Prospectus supplement
4:42pm
S-4/A
jlpw4gw5bl9 u685f
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.18
rt9oofq
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
EX-10.18
z529x5jxn
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
9wee3e2xgrogx5e
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
gpqj0968470ldb
18 Mar 21
Financial Statements and Exhibits
9:08am
- Prev
- 1
- Next